share_log

科伦药业:长江证券承销保荐有限公司关于四川科伦药业股份有限公司分拆所属子公司伊犁川宁生物技术股份有限公司至创业板上市的持续督导核查意见暨持续督导总结报告

Colon Pharmaceutical: Continued Supervision and Inspection Opinions and Continued Supervision Summary Report of Changjiang Securities Underwriting and Sponsorship Co., Ltd. on the spin-off of the subsidiary Yili Chuanning Biotechnology Co., Ltd. from Sichuan Colon Pharmaceutical Co., Ltd. to GEM listing

Sensex a share ·  Apr 24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more